Research output per year
Research output per year
Fingerprint
Dive into the research topics where Ettore D'Argento is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078] (ESMO Open (2021) 6(2), (S205970292100034X), (10.1016/j.esmoop.2021.100078))
Banna, G. L., Cortellini, A., Cortinovis, D. L., Tiseo, M., Aerts, J. G. J. V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R. & 26 others, , Jun 2021, In: ESMO Open. 6, 3, 100137.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Cortellini, A., Di Maio, M., Nigro, O., Leonetti, A., Cortinovis, D. L., Aerts, J. G. J. V., Guaitoli, G., Barbieri, F., Giusti, R., Ferrara, M. G., Bria, E., D'Argento, E., Grossi, F., Rijavec, E., Guida, A., Berardi, R., Torniai, M., Sforza, V., Genova, C., Mazzoni, F. & 41 others, , 2021, In: Journal for ImmunoTherapy of Cancer. 9, 4, e002421.Research output: Contribution to journal › Article › peer-review
-
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy
Cortellini, A., Di Maio, M., Nigro, O., Leonetti, A., Cortinovis, D. L., Aerts, J. G. J. V., Guaitoli, G., Barbieri, F., Giusti, R., Ferrara, M. G., Bria, E., D'Argento, E., Grossi, F., Rijavec, E., Guida, A., Berardi, R., Torniai, M., Sforza, V., Genova, C., Mazzoni, F. & 30 others, , Apr 7 2021, In: Journal for ImmunoTherapy of Cancer. 9, 4, p. e002421Research output: Contribution to journal › Article › peer-review
Open Access -
Multimodal therapy for synchronous bone oligometastatic NSCLC: The role of surgery
Congedo, M. T., Nachira, D., Bertolaccini, L., Chiappetta, M., Zanfrini, E., Meacci, E., Vita, M. L., Lococo, F., D'Argento, E., Spaggiari, L. & Margaritora, S., 2021, (Accepted/In press) In: Journal of Surgical Oncology.Research output: Contribution to journal › Article › peer-review
-
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study
Cortellini, A., Cannita, K., Tiseo, M., Cortinovis, D. L., Aerts, J. G. J. V., Baldessari, C., Giusti, R., Ferrara, M. G., D'Argento, E., Grossi, F., Guida, A., Berardi, R., Morabito, A., Genova, C., Antonuzzo, L., Mazzoni, F., De Toma, A., Signorelli, D., Gelibter, A., Targato, G. & 32 others, , 2021, In: European Journal of Cancer. 148, p. 24-35 12 p.Research output: Contribution to journal › Article › peer-review